Research has indicated that musarin significantly inhibits the proliferation of different colorectal cancer cells in a dose-dependent manner, and it particularly inhibits the proliferation of CD24+ CD44+ HT29 cells with CSC characteristics. This evidence concerns the gene CD44 and colorectal cancer.